City

Bahir Dar (1)

Chake Chake (1)

Manhica (1)

Nairobi (1)

Condition

Helminthes; Infestation, Intestinal (2)

Ascariasis (1)

Hookworm Infections (1)

Trichuriasis (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 2/phase 3 (2)

Sponsor

Barcelona Institute for Global Health (1)

Jennifer Keiser (1)

Collaborator

Bahir Dar University (1)

Centro de Investigacao em Saude de Manhica (1)

European and Developing Countries Clinical Trials Partnership (EDCTP) (1)

Kenya Medical Research Institute (1)

Laboratorios Liconsa (1)

Leiden University Medical Center (1)

London School of Hygiene and Tropical Medicine (1)

Public Health Laboratory Ivo de Carneri (1)

Universidad de Leon (1)

Intervention

albendazole (1)

albendazole 400 mg oral tablet [zentel] (1)

albendazole and ivermectin fixed dose coformulation (1)

ivermectin (200 µg/kg) (1)

ivermectin (200 µg/kg) / albendazole (400 mg) (1)

moxidectin (8 mg) (1)

moxidectin (8 mg) / albendazole (400 mg) (1)

Study Documents

Intervention Type

drug (2)

combination product (1)

Funder Type

Other (2)

Study Type

Interventional (2)

helminthes; infestation, intestinal

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Helminthes; Infestation, Intestinal Trial in Nairobi (Albendazole and Ivermectin fixed dose coformulation, Albendazole)

Recruiting

Helminthes; Infestation, Intestinal

Albendazole and Ivermectin fixed dose coformulation
Albendazole

Bahir Dar, Ethiopia
+2 more

Dec 16, 2022

Trichuriasis, Ascariasis, Hookworm Infections Trial in Chake Chake (moxidectin (8 mg) / albendazole (400 mg), ivermectin (200

Completed

Trichuriasis
+3 more

moxidectin (8 mg) / albendazole (400 mg)
+4 more

Chake Chake, Pemba, Tanzania

Public Health Laboratory Ivo de Carneri

Jan 31, 2022